In re P3 Health Group Holdings, LLC

Court of Chancery of Delaware·Decided October 14, 2022·No. C.A. No. 2021-0518-JTL·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

IN RE P3 HEALTH GROUP ) Consol. C.A. No. 2021-0518-JTL HOLDINGS, LLC )

MEMORANDUM OPINION

Date Submitted: July 13, 2022 Date Decided: October 14, 2022

Bruce E. Jameson, Corinne Elise Amato, Eric J. Juray, Elizabeth Wang, PRICKETT, JONES & ELLIOTT, P.A., Wilmington, Delaware; Craig Carpenito, Richard H. Walker, Samuel C. Cortina, KING & SPALDING LLP, New York, New York; Counsel for Hudson Vegas Investment SPV, LLC.

William M. Lafferty, Kevin M. Coen, Ryan D. Stottmann, Sara Toscano, MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, Delaware; Counsel for Jessica Puathasnanon and P3 Health Group Holdings, LLC.

Kevin R. Shannon, Christopher N. Kelly, Daniel M. Rusk IV, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; William K. Kane, J, SHEPPARD MULLIN RICHTER & HAMPTON LLP, Chicago, Illinois; James C. Wald, SHEPPARD MULLIN RICHTER & HAMPTON LLP, Los Angeles, California; Counsel for Chicago Pacific Founders Fund, L.P., CPF P3 Splitter, LLC, Greg Kazarian, Larry Leisure, Mary Tolan, and Sameer Mathur.

Elena C. Norman, Paul J. Loughman, Lakshmi A. Muthu, Alberto E. Chávez, YOUNG CONAWAY STARGATT & TAYLOR LLP, Wilmington, Delaware; Counsel for Sherif W. Abdou, Amir Bacchus, Gary Garrett, Lorie Glisson, Taylor Leavitt, and Tom Price.

Steven T. Margolin, Samuel L. Moultrie, Corrinne R. Moini, GREENBERG TRAURIG, LLP, Wilmington, Delaware; Counsel for Foresight Acquisition Corporation, Foresight Acquisition Corporation II, and Greg Wasson.

LASTER, V.C.

Greg Wasson formed a Delaware corporation that went public as a special purpose acquisition company (“SPAC”). At the time, Wasson had been in discussions for several months with representatives of a target company about a merger with the to-be-launched SPAC. After the launch, the discussions continued. To effectuate the eventual merger, Wasson formed a second Delaware entity—a limited liability company and subsidiary of the SPAC. When the merger closed, it took the form of a forward triangular merger between the target company and the LLC subsidiary of the SPAC.

In this action, the plaintiff has sued Wasson based on actions he took in connection with the merger. Wasson has moved to dismiss those claims both on the merits and on the theory that he is not subject to personal jurisdiction in Delaware. This decision denies the latter motion.

A proper exercise of personal jurisdiction must satisfy two requirements. First, there must be a valid means of serving the defendant with a summons. Second, the exercise of jurisdiction over the defendant must comply with minimum standards of due process.

Under the Delaware Long Arm Statute, a party may serve any person who directly or through an agent “[t]ransacts any business or performs any character of work or service in the State . . . .” 10 Del. C. § 3104(c)(1). The formation of a Delaware entity constitutes the transaction of business in the State and is sufficient to support the service of process for purposes of claims that have a nexus with the formation of the Delaware entity.

Wasson’s formation of two Delaware entities constitutes the transaction of business within the State of Delaware. Each is sufficient independently to support the service of

process on Wasson for purposes of a claim relating to the forward triangular merger among the target company, the LLC, and the SPAC.

The exercise of personal jurisdiction over Wasson comports with minimum standards of due process. The choice to form a Delaware entity creates a significant contact with the State. An individual who causes the formation of a Delaware entity for the purpose of engaging in a transaction must expect to be subject to suit in Delaware for claims based on the resulting transaction. That has been the law for over forty years. Papendick v. Bosch, 410 A.2d 148, 152 (Del. 1978).

The complaint accordingly supports a reasonable inference that personal jurisdiction exists over Wasson. His jurisdictional motion is denied.

I. FACTUAL BACKGROUND The facts are drawn from the plaintiff’s complaint and the documents it incorporates by reference. At this stage of the proceedings, the complaint’s allegations are assumed to be true, and the plaintiff receives the benefit of all reasonable inferences. A. The Company P3 Health Group Holdings, LLC (“P3” or the “Company”) is a Delaware limited liability company that engages in the business of population healthcare management, a concept that involves providing patient-members with better and more cost-effective long- term healthcare. Chicago Pacific is a private equity fund focused on investments in the healthcare industry. Chicago Pacific provided the original capital for the Company and has exercised control over the Company since its founding. One of the rights that Chicago

Pacific enjoys is the ability to appoint managers to the Company’s governing board (the “Chicago Pacific Managers”).

Hudson Vegas Investment SPV, LLC (“Hudson”) subsequently invested in the Company. Hudson became the Company’s second largest investor after Chicago Pacific. Hudson also enjoys is ability to appoint managers to the Company’s governing board (the “Hudson Managers”). B. The Original Deal Structure In August 2020, the Company began exploring ways to access the public markets.

In September, several members of the Company’s board of managers (the “Board”) held a Zoom meeting on that subject. The meeting materials listed a potential combination with another Chicago Pacific portfolio company as one of the paths available to the Company.

On November 1, 2020, Wasson met with three members of the Board. Wasson is a successful executive who conducts business through his family office, Wasson Enterprises. For purposes of this decision, the distinction between Wasson and his family office is not important, so this decision refers to Wasson.

During the meeting, Wasson and the Board members discussed the benefits of the Company going public by merging with a SPAC. One possibility was for Wasson to create a SPAC, use it to raise public capital through an initial public offering, and then cause the SPAC to merge with the Company.

By late November 2020, Wasson and the Company were discussing a potential three-way merger involving the Company, a SPAC that Wasson would form, and another portfolio company controlled by Chicago Pacific (the “Original Deal Structure”). Wasson

and Chicago Pacific entered into a non-disclosure agreement, exchanged confidential information, and prepared detailed financial models. By December, Wasson was ready to move forward with the Original Deal Structure.

In early January 2021, the Chicago Pacific Managers proposed to the Board that the Company pursue a transaction using the Original Deal Structure. Around the same time, Wasson formed a Delaware corporation named Foresight Acquisition Corp. Later that month, Foresight filed its Registration Statement on Form S-1 and raised capital through an initial public offering. After the IPO, Foresight’s shares traded publicly on NASDAQ under the ticker symbol “FORE.” C. The New Deal Structure Under the Company’s LLC agreement, any transaction between the Company and another affiliate of Chicago Pacific required Hudson’s approval. Because the Original Deal Structure contemplated a transaction involving another Chicago Pacific portfolio company, it required Hudson’s approval. Hudson did not like the economics of the Original Deal Structure and withheld its consent.

Free access — add to your briefcase to read the full text and ask questions with AI

In re P3 Health Group Holdings, LLC, (Del. Ct. App. 2022).

In re P3 Health Group Holdings, LLC (In re P3 Health Group Holdings, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Ryan v. Gifford
935 A.2d 258 (Court of Chancery of Delaware, 2007)
Sample v. Morgan
935 A.2d 1046 (Court of Chancery of Delaware, 2007)
Papendick v. Robert Bosch GmbH
410 A.2d 148 (Supreme Court of Delaware, 1979)
In Re USACafes, L.P. Litigation
600 A.2d 43 (Court of Chancery of Delaware, 1991)
LaNUOVA D & B, SpA v. Bowe Co., Inc.
513 A.2d 764 (Supreme Court of Delaware, 1986)
Istituto Bancario Italiano SpA v. Hunter Engineering Co.
449 A.2d 210 (Supreme Court of Delaware, 1982)
Aeroglobal Capital Management, LLC v. Cirrus Industries, Inc.
871 A.2d 428 (Supreme Court of Delaware, 2005)
Crescent/Mach I Partners, L.P. v. Turner
846 A.2d 963 (Court of Chancery of Delaware, 2000)
Eudaily v. Harmon Ex Rel. Harmon
420 A.2d 1175 (Supreme Court of Delaware, 1980)
Hamilton Partners, L.P. v. Englard
11 A.3d 1180 (Court of Chancery of Delaware, 2010)
Matthew v. Fläkt Woods Group SA
56 A.3d 1023 (Supreme Court of Delaware, 2012)